Loading
DT
Dimension Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ORBIMED ADVISORS LLC, was filed 29 Oct 2015.
Dimension Therapeutics, Inc.: what insiders have been doing
Dimension Therapeutics, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Dimension Therapeutics, Inc. The previous disclosure was published on 9 November 2017.
Since 2015, the database holds 2 purchases and 1 sale by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
16
Thresholds
n/a
Buy Volume
€14M
2 ops. · all time
Sell Volume
€44,023
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
Revenue10.2M
Net income-43.7M-427.2% margin
Last declaration on 9 November 2017
Declarations16 total
3,838,249 shares@ US$6.0078.4% of flowCommon StockSEC:0000315066-17-002872:0
1,050,016 shares@ US$6.0021.5% of flowCommon StockSEC:0000315066-17-002872:1
5,057 shares@ US$6.000.1% of flowCommon StockSEC:0000315066-17-002872:2
278,035 sharesCommon StockSEC:0001209191-17-059634:0
5,000 shares@ US$0.383.7% of flowCommon StockSEC:0001209191-16-126674:0
5,000 shares@ US$10.0096.3% of flowCommon StockSEC:0001209191-16-126674:1
2,106,784 shares0Common StockSEC:0000315066-16-005776:0
3,250,085 sharesCommon StockSEC:0001104659-15-074205:0
1,947,613 sharesCommon StockSEC:0001104659-15-074205:1
1,097,745 sharesCommon StockSEC:0001104659-15-074204:0
961,538 shares@ US$13.00Common StockSEC:0001104659-15-074204:1
Canonical exit: 25 Jan 2016 (T+90)
5,131,713 sharesCommon StockSEC:0000315066-15-003188:0
1,628,914 sharesCommon StockSEC:0000315066-15-003188:1
3,250,085 sharesCommon StockSEC:0001104659-15-074206:0
1,947,613 sharesCommon StockSEC:0001104659-15-074206:1
200,000 shares@ US$13.00Common StockSEC:0001104659-15-074206:2
Canonical exit: 25 Jan 2016 (T+90)
16 of 16 declarations
About Dimension Therapeutics, Inc.
Dimension Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapies for hereditary diseases. It is listed on NASDAQ under the ticker XNAS.
